Product Liability Complaint - District of Columbia

PRODUCT LIABILITY COMPLAINT - DISTRICT OF COLUMBIA

TABLE OF CONTENTS

1. Caption
2. Introduction
3. Parties
4. Jurisdiction and Venue
5. Factual Allegations
6. Count I - Strict Products Liability: Manufacturing Defect
7. Count II - Strict Products Liability: Design Defect (Risk-Utility)
8. Count III - Strict Products Liability: Failure to Warn
9. Count IV - Negligence
10. Count V - Breach of Implied Warranty of Merchantability
11. Count VI - Breach of Implied Warranty of Fitness for a Particular Purpose
12. Count VII - Breach of Express Warranty
13. Damages
14. Prayer for Relief
15. Demand for Jury Trial
16. Reservation of Rights
17. Signature and Service Blocks
18. Verification
19. Certificate of Service
20. District of Columbia Practice Notes
21. Sources and References

1. CAPTION

SUPERIOR COURT OF THE DISTRICT OF COLUMBIA

CIVIL DIVISION

Civil Action No. [________________________________]

Calendar / Track: [____]

COMPLAINT FOR DAMAGES (PRODUCT LIABILITY) AND DEMAND FOR JURY TRIAL

2. INTRODUCTION

Plaintiff [PLAINTIFF NAME] ("Plaintiff"), by and through undersigned counsel, brings this action against Defendants [MANUFACTURER], [DISTRIBUTOR], [SELLER], and unknown John and Jane Does 1-10 (collectively, "Defendants") for damages arising from injuries sustained in connection with a defective and unreasonably dangerous [PRODUCT NAME / TYPE] (the "Product") that Defendants designed, manufactured, marketed, distributed, and/or sold. In support of this Complaint, Plaintiff alleges as follows:

3. PARTIES

3.1. Plaintiff [PLAINTIFF NAME] is a natural person and a resident of [CITY, STATE], who at all relevant times has been competent to file this action.

3.2. Defendant [MANUFACTURER NAME] ("Manufacturer") is a [STATE] corporation with its principal place of business at [ADDRESS], and is in the business of designing, testing, manufacturing, marketing, and selling [PRODUCT TYPE] in the United States, including in the District of Columbia.

3.3. Defendant [DISTRIBUTOR NAME] ("Distributor") is a [STATE] [CORPORATION / LLC] with its principal place of business at [ADDRESS], and is in the business of distributing and supplying [PRODUCT TYPE] to retailers, wholesalers, and consumers in the District of Columbia.

3.4. Defendant [SELLER NAME] ("Seller") is a [STATE] [CORPORATION / LLC] with retail operations in the District of Columbia at [ADDRESS], and is in the business of selling [PRODUCT TYPE] to the public.

3.5. Defendants John and Jane Does 1-10 are individuals or entities, presently unknown to Plaintiff, who designed, manufactured, distributed, sold, serviced, or otherwise placed the Product into the stream of commerce. Plaintiff will seek leave to amend this Complaint to identify these defendants by their true names once their identities are ascertained.

3.6. At all relevant times, each Defendant was acting individually and/or as the agent, employee, partner, joint venturer, or alter ego of each of the other Defendants, and each Defendant ratified the acts and omissions of the others.

4. JURISDICTION AND VENUE

4.1. This Court has subject-matter jurisdiction over this action pursuant to D.C. Code § 11-921, which vests the Superior Court of the District of Columbia with general civil jurisdiction.

4.2. This Court has personal jurisdiction over each Defendant pursuant to D.C. Code § 13-423 (the District of Columbia long-arm statute), in that each Defendant: (a) transacts business in the District of Columbia; (b) caused tortious injury in the District of Columbia by an act or omission in the District of Columbia; and/or (c) caused tortious injury in the District of Columbia by an act or omission outside the District while regularly doing or soliciting business, engaging in a persistent course of conduct, or deriving substantial revenue from goods used or consumed in the District.

4.3. Venue is proper in the Superior Court of the District of Columbia because the Product was sold, used, and caused injury within the District of Columbia.

4.4. This action is timely under D.C. Code § 12-301(8), which provides a three-year limitations period for personal injury actions to which no other limitation is specifically prescribed. Plaintiff's cause of action accrued no earlier than [DATE OF INJURY OR DATE OF DISCOVERY], and this Complaint is filed within three years of accrual.

5. FACTUAL ALLEGATIONS

5.1. On or about [DATE OF PURCHASE], the Product, identified as [MAKE / MODEL / SERIAL OR LOT NUMBER], was purchased from Defendant [SELLER] at [LOCATION] in the District of Columbia for the use for which it was designed, manufactured, advertised, and sold.

5.2. The Product was designed, manufactured, assembled, tested, inspected, packaged, marketed, distributed, and/or sold by Defendants, and was placed by Defendants into the stream of commerce.

5.3. At all relevant times, the Product was used in a manner that was reasonably foreseeable and consistent with the purposes for which Defendants designed and marketed it.

5.4. On [DATE OF INJURY], while Plaintiff was using the Product in its intended and reasonably foreseeable manner, the Product [DESCRIBE FAILURE - e.g., catastrophically failed, malfunctioned, ignited, fragmented, exposed Plaintiff to a latent hazard], causing severe and permanent injury to Plaintiff (the "Incident").

5.5. As a direct and proximate result of the Incident, Plaintiff suffered [DESCRIBE INJURIES - e.g., traumatic amputation of the right hand, third-degree burns, traumatic brain injury, internal organ damage] and required emergency transport to [HOSPITAL], where Plaintiff was admitted for [NUMBER] days and underwent [SURGICAL / MEDICAL TREATMENTS].

5.6. Plaintiff was using the Product with the care and caution that a reasonable, prudent person would use under like circumstances, and Plaintiff in no way contributed to the Incident or to Plaintiff's injuries.

5.7. The Product reached Plaintiff without substantial change in the condition in which it was sold, and was at all relevant times in substantially the same condition as when it left Defendants' control.

5.8. The defect that caused the Incident was not open or obvious to an ordinary consumer, was not the result of any modification, alteration, or misuse by Plaintiff, and existed at the time the Product left Defendants' possession and control.

6. COUNT I - STRICT PRODUCTS LIABILITY: MANUFACTURING DEFECT

6.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 5.8 as if fully set forth herein.

6.2. The District of Columbia has adopted Section 402A of the Restatement (Second) of Torts as the governing standard for strict products liability. Payne v. Soft Sheen Products, Inc., 486 A.2d 712, 720-22 (D.C. 1985).

6.3. Defendants were in the business of designing, manufacturing, distributing, and selling the Product, and the Product was expected to and did reach Plaintiff without substantial change in its condition.

6.4. The Product as it left Defendants' possession deviated from its intended design and from other units of the same product line, and contained a manufacturing defect that rendered it unreasonably dangerous when used in its intended and reasonably foreseeable manner. Specifically, [DESCRIBE MANUFACTURING DEFECT - e.g., a weld that fell below specified tensile strength, contamination of the active pharmaceutical ingredient, failure to install required component].

6.5. The manufacturing defect was a direct and proximate cause of the Incident and Plaintiff's resulting injuries.

6.6. Defendants are strictly liable for all injuries and damages caused by the manufacturing defect.

7. COUNT II - STRICT PRODUCTS LIABILITY: DESIGN DEFECT (RISK-UTILITY)

7.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 6.6 as if fully set forth herein.

7.2. Under District of Columbia law, the test for design defect in a strict-liability action is the risk-utility balancing test announced in Warner Fruehauf Trailer Co. v. Boston, 654 A.2d 1272, 1274 (D.C. 1995). The factfinder weighs (a) the magnitude of the foreseeable danger; (b) the likelihood of harm; (c) the burden, cost, and feasibility of an alternative safer design; (d) the utility of the Product; and (e) the availability and adequacy of warnings and instructions.

7.3. The Product was defectively designed in that, among other reasons:

• The Product lacked [REQUIRED SAFETY FEATURE - e.g., guard, interlock, fail-safe, redundant restraint] that was technologically and economically feasible at the time of design;
• The Product's design created an unreasonable risk of [HAZARD - e.g., sudden mechanical failure, free-fall, electrical shock, fire, ignition, unintended activation] during ordinary and foreseeable use;
• A safer alternative design existed that would have prevented or substantially reduced the risk of harm without impairing the utility of the Product or imposing undue cost;
• The magnitude of the danger from the Product as designed outweighed the costs of avoiding the danger.

7.4. The design defect rendered the Product unreasonably dangerous to ordinary consumers and to users such as Plaintiff.

7.5. The design defect existed at the time the Product left Defendants' control and was a direct and proximate cause of the Incident and Plaintiff's injuries.

7.6. Defendants are strictly liable for all injuries and damages caused by the design defect.

8. COUNT III - STRICT PRODUCTS LIABILITY: FAILURE TO WARN

8.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 7.6 as if fully set forth herein.

8.2. A product may be unreasonably dangerous, and its manufacturer or seller may be strictly liable, where the manufacturer fails to provide adequate warnings of foreseeable risks of harm. Payne v. Soft Sheen Products, Inc., 486 A.2d 712, 722-25 (D.C. 1985).

8.3. At the time the Product left Defendants' control, Defendants knew, or in the exercise of reasonable care should have known, of the foreseeable risk of [HAZARD] associated with use of the Product, including risks of [INJURY TYPE].

8.4. Defendants failed to provide warnings and instructions adequate to apprise foreseeable users such as Plaintiff of the existence, nature, and gravity of the risk and of the steps necessary to use the Product safely. Specifically:

• The Product's labeling, packaging, and accompanying materials contained no warning, or only an inadequate warning, of [SPECIFIC RISK];
• The warnings provided failed to use language, position, or prominence calculated to convey the gravity of the risk to a foreseeable user;
• Defendants failed to issue post-sale warnings, recalls, or service bulletins after they became aware of the hazard.

8.5. Had adequate warnings been given, Plaintiff would have heeded them and would not have been injured. Plaintiff is entitled to the rebuttable presumption announced in Payne that a foreseeable user would have read and heeded an adequate warning.

8.6. The failure to warn was a direct and proximate cause of the Incident and Plaintiff's injuries, and Defendants are strictly liable for all resulting damages.

9. COUNT IV - NEGLIGENCE

9.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 8.6 as if fully set forth herein.

9.2. Defendants owed Plaintiff a duty of reasonable care in the design, manufacture, testing, inspection, marketing, distribution, sale, and post-sale monitoring of the Product.

9.3. Defendants breached that duty by, among other things:

• Negligently designing the Product to incorporate the defects described above;
• Negligently manufacturing, assembling, and inspecting the Product;
• Negligently failing to test the Product against reasonably foreseeable use scenarios;
• Negligently failing to warn of foreseeable hazards;
• Negligently failing to recall, retrofit, or issue post-sale warnings after Defendants knew or should have known of the defect.

9.4. Defendants' negligence was a direct and proximate cause of the Incident and Plaintiff's injuries.

9.5. At all times material hereto, Plaintiff was free from any contributory negligence, exercised reasonable care for Plaintiff's own safety, and did not assume the risk of the harm that occurred.

10. COUNT V - BREACH OF IMPLIED WARRANTY OF MERCHANTABILITY

10.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 9.5 as if fully set forth herein.

10.2. Defendants are merchants with respect to [PRODUCT TYPE] within the meaning of D.C. Code § 28:2-104.

10.3. Pursuant to D.C. Code § 28:2-314, an implied warranty that the Product was merchantable arose with respect to the Product's sale.

10.4. The Product was not merchantable in that, among other defects, it was not fit for the ordinary purposes for which [PRODUCT TYPE] is used and would not pass without objection in the trade.

10.5. The breach of the implied warranty of merchantability was a direct and proximate cause of the Incident and Plaintiff's injuries.

10.6. Plaintiff is a person whom Defendants might reasonably have expected to use, consume, or be affected by the Product within the meaning of D.C. Code § 28:2-318.

11. COUNT VI - BREACH OF IMPLIED WARRANTY OF FITNESS FOR A PARTICULAR PURPOSE

11.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 10.6 as if fully set forth herein.

11.2. At the time of sale, Defendants knew or had reason to know of the particular purpose for which Plaintiff required the Product, namely [PARTICULAR PURPOSE], and knew or had reason to know that Plaintiff was relying on Defendants' skill and judgment in selecting or furnishing a suitable Product.

11.3. Pursuant to D.C. Code § 28:2-315, an implied warranty arose that the Product was fit for that particular purpose.

11.4. The Product was not fit for that particular purpose, and the breach of warranty was a direct and proximate cause of the Incident and Plaintiff's injuries.

12. COUNT VII - BREACH OF EXPRESS WARRANTY

12.1. Plaintiff realleges and incorporates Paragraphs 1.1 through 11.4 as if fully set forth herein.

12.2. Defendants made affirmations of fact and promises about the Product to Plaintiff and other foreseeable users, including representations that the Product was [SAFE / RELIABLE / TESTED / CERTIFIED / SUITABLE FOR ITS INTENDED USE], in [ADVERTISING / PACKAGING / LABELING / MANUALS / WEBSITE] (collectively, the "Express Representations").

12.3. The Express Representations became part of the basis of the bargain pursuant to D.C. Code § 28:2-313.

12.4. The Product did not conform to the Express Representations, and the breach was a direct and proximate cause of the Incident and Plaintiff's injuries.

13. DAMAGES

13.1. Past Medical Expenses. Plaintiff has incurred reasonable and necessary medical expenses to date in an amount of approximately $[AMOUNT], and continues to incur such expenses.

13.2. Future Medical Expenses. Plaintiff will require continuing medical care, surgical revisions, prosthetics, rehabilitation, and life-care support, the present value of which will be proven at trial.

13.3. Lost Earnings and Earning Capacity. Plaintiff has lost wages and benefits to date and has suffered a permanent diminution of earning capacity, the value of which will be proven at trial.

13.4. Pain, Suffering, and Loss of Enjoyment of Life. Plaintiff has suffered, and will continue to suffer, severe physical pain, mental anguish, scarring, disfigurement, and loss of enjoyment of life.

13.5. Property Damage. Plaintiff has incurred property damage in the amount of $[AMOUNT].

13.6. Punitive Damages. Defendants' conduct was willful, wanton, malicious, fraudulent, and/or in reckless disregard of the rights and safety of Plaintiff and other foreseeable users, justifying an award of punitive damages under District of Columbia law. (DC has no statutory cap on punitive damages, but they must be proven by clear and convincing evidence.)

14. PRAYER FOR RELIEF

WHEREFORE, Plaintiff respectfully requests that this Court enter judgment in Plaintiff's favor and against Defendants, jointly and severally, and grant the following relief:

• A. Compensatory damages in an amount to be proven at trial, in excess of any minimum jurisdictional threshold;
• B. Punitive damages in an amount sufficient to punish and deter Defendants' wrongful conduct;
• C. Pre-judgment and post-judgment interest at the maximum rate allowed by law;
• D. Costs of suit, including reasonable expert witness fees;
• E. Reasonable attorney's fees where authorized by statute or contract; and
• F. Such other and further relief as the Court deems just and proper.

15. DEMAND FOR JURY TRIAL

Plaintiff hereby demands a trial by jury on all issues so triable as a matter of right, pursuant to D.C. Super. Ct. R. Civ. P. 38.

16. RESERVATION OF RIGHTS

Plaintiff reserves the right to amend this Complaint pursuant to D.C. Super. Ct. R. Civ. P. 15 to add additional claims, parties, or theories of recovery as discovery may reveal, including but not limited to claims under the District of Columbia Consumer Protection Procedures Act (D.C. Code § 28-3901 et seq.) and claims against newly-identified Doe defendants.

17. SIGNATURE AND SERVICE BLOCKS

Date: [DATE]

Respectfully submitted,

[LAW FIRM NAME]

By: [________________________________]

[ATTORNEY NAME], D.C. Bar No. [####]

[CO-COUNSEL NAME], D.C. Bar No. [####]

Counsel for Plaintiff

[STREET ADDRESS]

[CITY, STATE ZIP]

Telephone: [NUMBER]

Facsimile: [NUMBER]

Email: [EMAIL]

18. VERIFICATION

DISTRICT OF COLUMBIA

I, [PLAINTIFF NAME], being duly sworn, state under penalty of perjury that I am the Plaintiff in the foregoing action; that I have read the foregoing Complaint and know the contents thereof; and that the same is true to my own knowledge except as to those matters stated upon information and belief, and as to those I believe them to be true.

[________________________________]

[PLAINTIFF NAME]

Sworn to and subscribed before me this [____] day of [_______________], 20[____].

[________________________________]

Notary Public

(My Commission Expires: [_______________])

19. CERTIFICATE OF SERVICE

I hereby certify that on this [____] day of [_______________], 20[____], the foregoing COMPLAINT was filed via the Court's electronic filing system and served on all counsel of record via the Court's electronic notification system, and on each non-CM/ECF party via [METHOD - e.g., personal service, certified mail, return receipt requested] at the addresses listed below:

[SERVICE LIST WITH ADDRESSES]

[________________________________]

[ATTORNEY NAME]

20. DISTRICT OF COLUMBIA PRACTICE NOTES

• Pure contributory negligence (CRITICAL). The District of Columbia is one of only five U.S. jurisdictions (with Alabama, Maryland, North Carolina, and Virginia) that retains the rule that any contributory negligence by the plaintiff completely bars recovery in a negligence action. Wingfield v. Peoples Drug Store, Inc., 379 A.2d 685 (D.C. 1977). Even 1% plaintiff fault defeats the claim, subject to the narrow last-clear-chance doctrine. The District has carved out a partial statutory exception for non-motorized users (pedestrians, cyclists, etc.) in motor-vehicle collisions under the Motor Vehicle Collision Recovery Act, D.C. Code § 50-2204.52, but this does NOT apply to product-liability claims. Plead the plaintiff's exercise of due care affirmatively and develop facts in discovery to negate any contributory-negligence theory.
• Strict liability vs. contributory negligence. Ordinary contributory negligence is NOT a defense to strict products liability in the District of Columbia. Bowler v. Stewart-Warner Corp., 563 A.2d 344 (D.C. 1989). Assumption of risk and product misuse remain valid defenses to strict-liability counts. Counsel should consider whether to drop the negligence count in cases of marginal plaintiff fault and proceed solely under strict liability and warranty theories.
• Strict liability standard. DC has adopted Restatement (Second) of Torts § 402A. Payne v. Soft Sheen Products, Inc., 486 A.2d 712 (D.C. 1985). Manufacturing defect is evaluated under a deviation-from-design standard; design defect is evaluated under the risk-utility balancing test of Warner Fruehauf Trailer Co. v. Boston, 654 A.2d 1272 (D.C. 1995); failure-to-warn is evaluated under the foreseeability/adequacy standard with the rebuttable read-and-heed presumption announced in Payne.
• Learned intermediary doctrine. For prescription drugs and medical devices, the manufacturer's duty to warn runs to the prescribing physician, not the patient. Mampe v. Ayerst Laboratories, 548 A.2d 798 (D.C. 1988). The plaintiff must plead and prove that an adequate warning to the physician would have changed the prescribing decision.
• Statute of limitations. Three years from accrual under D.C. Code § 12-301(8) for personal injury claims. The discovery rule applies. Wrongful-death actions under D.C. Code § 16-2702 carry a separate two-year limitation. Survival actions under D.C. Code § 12-101 piggyback on the underlying tort limitation.
• Wrongful death. A wrongful-death action lies in the personal representative of the decedent's estate under D.C. Code § 16-2701, with damages limited to pecuniary loss to the statutory beneficiaries. Survival actions for the decedent's pre-death pain, suffering, and economic losses are brought under D.C. Code § 12-101.
• Punitive damages. No statutory cap, but plaintiff must prove by clear and convincing evidence that the defendant acted with evil motive, actual malice, deliberate violence, or willful disregard. Daka, Inc. v. McCrae, 839 A.2d 682 (D.C. 2003).
• Service of process. Super. Ct. R. Civ. P. 4 governs service. For corporate defendants, service is generally on the registered agent listed with the DC Department of Licensing and Consumer Protection (DLCP). Foreign defendants are served via the long-arm statute, D.C. Code § 13-423.
• Removal exposure. A non-DC corporate defendant is likely to remove to the U.S. District Court for the District of Columbia under 28 U.S.C. §§ 1332, 1441 if the amount in controversy exceeds $75,000 and complete diversity exists. Joinder of a non-diverse seller / distributor may defeat removal but is subject to fraudulent-joinder challenge.
• Filing logistics. Civil filings are submitted through the Court's CaseFileXpress / eFileDC system. Filing fee for a civil complaint is [VERIFY CURRENT FEE]. Initial scheduling conference will be set under Super. Ct. R. Civ. P. 16.

21. SOURCES AND REFERENCES

• D.C. Code § 12-301 (Limitation of time for bringing actions) - https://code.dccouncil.gov/us/dc/council/code/sections/12-301
• D.C. Code § 13-423 (Long-arm statute) - https://code.dccouncil.gov/us/dc/council/code/sections/13-423
• D.C. Code Title 28, Subtitle I (Uniform Commercial Code - Sales) - https://code.dccouncil.gov/us/dc/council/code/titles/28
• D.C. Superior Court Rules of Civil Procedure - https://www.dccourts.gov/superior-court/civil-division
• Payne v. Soft Sheen Products, Inc., 486 A.2d 712 (D.C. 1985) - https://law.justia.com/cases/district-of-columbia/court-of-appeals/1985/83-1218-3.html
• Warner Fruehauf Trailer Co. v. Boston, 654 A.2d 1272 (D.C. 1995) - https://law.justia.com/cases/district-of-columbia/court-of-appeals/1995/93-cv-173-6.html
• Mampe v. Ayerst Laboratories, 548 A.2d 798 (D.C. 1988) - https://law.justia.com/cases/district-of-columbia/court-of-appeals/1988/87-678-4.html
• Wingfield v. Peoples Drug Store, Inc., 379 A.2d 685 (D.C. 1977) - https://law.justia.com/cases/district-of-columbia/court-of-appeals/1977/11243-3.html
• Bowler v. Stewart-Warner Corp., 563 A.2d 344 (D.C. 1989) - https://law.justia.com/cases/district-of-columbia/court-of-appeals/1989/86-1134-4.html
• Restatement (Second) of Torts § 402A (American Law Institute, 1965)

Disclaimer: This template is provided for informational purposes only and does not constitute legal advice. An attorney admitted to the District of Columbia Bar must review and customize this document before filing. Laws, citations, and court rules change frequently; verify all authorities before use.